{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:56:45Z","timestamp":1792515405732,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":2283,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AI113916\u201001"],"award-info":[{"award-number":["1R21AI113916\u201001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI084146"],"award-info":[{"award-number":["U01 AI084146"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KO8 DK\u2010088946"],"award-info":[{"award-number":["KO8 DK\u2010088946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO3 DK102480"],"award-info":[{"award-number":["RO3 DK102480"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1111\/ajt.13765","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T23:56:50Z","timestamp":1456876610000},"page":"2532-2544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Protecting the Kidney in Liver Transplant Recipients: Practicee-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice"],"prefix":"10.1016","volume":"16","author":[{"given":"J.","family":"Levitsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Asrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.U.","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.13765_bib1","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/j.1600-6143.2011.03703.x","article-title":"Impact of MELD-based allocation on end-stage renal disease after liver transplantation","volume":"11","author":"Sharma","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib2","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/j.1600-6143.2012.04177.x","article-title":"Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction","volume":"12","author":"Ruebner","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib3","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/bja\/aeu556","article-title":"Acute kidney injury following orthotopic liver transplantation: Incidence, risk factors, and effects on patient and graft outcomes","volume":"114","author":"Hilmi","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1111\/ajt.13765_bib4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.transproceed.2014.05.053","article-title":"Acute kidney injury after liver transplantation: Incidence and mortality","volume":"46","author":"Klaus","year":"2014","journal-title":"Transpl Proc"},{"key":"10.1111\/ajt.13765_bib5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jhep.2014.02.019","article-title":"The evolving use of higher risk grafts is associated with an increased incidence of acute kidney injury after liver transplantation","volume":"60","author":"Leithead","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13765_bib6","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.transproceed.2014.09.161","article-title":"Comparison of RIFLE and AKIN criteria in the evaluation of the frequency of acute kidney injury in post-liver transplantation patients","volume":"46","author":"Karapanagiotou","year":"2014","journal-title":"Transpl Proc"},{"key":"10.1111\/ajt.13765_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-6143.2006.01602.x","article-title":"Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation","volume":"7","author":"O\u2019Riordan","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2014.03.034","article-title":"Chronic kidney disease and associated mortality after liver transplantation - A time-dependent analysis using measured glomerular filtration rate","volume":"61","author":"Allen","year":"2014","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13765_bib9","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1681\/ASN.2013040436","article-title":"Patient-specific prediction of ESRD after liver transplantation","volume":"24","author":"Sharma","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1111\/ajt.13765_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ajt.12021","article-title":"OPTN\/SRTR 2011 Annual Data Report: Liver","volume":"13","author":"Kim","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13765_bib12","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/lt.21951","article-title":"Effect of pretransplant serum creatinine on the survival benefit of liver transplantation","volume":"15","author":"Sharma","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib13","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib14","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: Current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/TP.0000000000000552","article-title":"Serum cystatin C as an indicator of renal function and mortality in liver transplant recipients","volume":"99","author":"Allen","year":"2015","journal-title":"Transplantation"},{"issue":"S1","key":"10.1111\/ajt.13765_bib16","first-page":"159A","article-title":"Acute tubular necrosis is present in the majority of patients undergoing liver transplantation","volume":"54","author":"Asrani","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13765_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/TP.0000000000000215","article-title":"Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy","volume":"98","author":"Wadei","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"key":"10.1111\/ajt.13765_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/lt.20994","article-title":"Different methods of creatinine measurement significantly affect MELD scores","volume":"13","author":"Cholongitas","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.ajkd.2014.01.436","article-title":"Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients","volume":"63","author":"Shaffi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.13765_bib21","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"De Souza","year":"2014","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13765_bib22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13765_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13765_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.13765_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jhep.2014.08.054","article-title":"Chronic kidney disease after liver transplantation","volume":"62","author":"Leithead","year":"2015","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13765_bib26","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1111\/j.1600-6143.2012.04182.x","article-title":"Outcomes and native renal recovery following simultaneous liver-kidney transplantation","volume":"12","author":"Levitsky","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/tri.12066","article-title":"Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: Initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans","volume":"26","author":"Vagefi","year":"2013","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.13765_bib28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.ki.5000216","article-title":"Risk factors of acute renal failure after liver transplantation","volume":"69","author":"Cabezuelo","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13765_bib29","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/ndt\/gfq077","article-title":"N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation","volume":"25","author":"Hilmi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.13765_bib30","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1213\/01.ANE.0000136420.01393.81","article-title":"Fenoldopam mesylate and renal function in patients undergoing liver transplantation: A randomized, controlled pilot trial","volume":"99","author":"Della Rocca","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1111\/ajt.13765_bib31","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/lt.20145","article-title":"Use of fenoldopam to control renal dysfunction early after liver transplantation","volume":"10","author":"Biancofiore","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1213\/ANE.0000000000000374","article-title":"Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: A single-center retrospective review","volume":"120","author":"Hand","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1111\/ajt.13765_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s13054-014-0625-7","article-title":"Chloride-liberal fluids are associated with acute kidney injury after liver transplantation","volume":"18","author":"Nadeem","year":"2014","journal-title":"Crit Care"},{"key":"10.1111\/ajt.13765_bib34","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1213\/ane.0b013e3181aed54f","article-title":"The safety of modern hydroxyethyl starch in living donor liver transplantation: A comparison with human albumin","volume":"109","author":"Mukhtar","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1111\/ajt.13765_bib35","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1600-6143.2005.00852.x","article-title":"Renal histopathological lesions after orthotopic liver transplantation (OLT)","volume":"5","author":"Pillebout","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib36","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/lt.21938","article-title":"Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin","volume":"15","author":"Niemann","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib37","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.510230618","article-title":"Effect of venovenous bypass on perioperative renal function in liver transplantation: Results of a randomized, controlled trial","volume":"23","author":"Grande","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13765_bib38","first-page":"CD003590","article-title":"Interventions for protecting renal function in the perioperative period","volume":"9","author":"Zacharias","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ajt.13765_bib39","doi-asserted-by":"crossref","unstructured":"O\u2019Leary JG, Levitsky J, Wong F, Nadim MK, Charlton M, Kim WR. Protecting the kidney in liver transplant candidates: Practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice. Am J Transplant 2016; doi: 10.1111\/ajt.13790.","DOI":"10.1111\/ajt.13790"},{"key":"10.1111\/ajt.13765_bib40","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/ajt.13765_bib41","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/hep.27346","article-title":"Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation","volume":"60","author":"Levitsky","year":"2014","journal-title":"Hepatology"},{"key":"10.1111\/ajt.13765_bib42","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ndt\/gfq770","article-title":"Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation","volume":"26","author":"Wagener","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.13765_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2369-14-17","article-title":"Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation","volume":"14","author":"Sirota","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1111\/ajt.13765_bib44","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib45","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/j.1600-6143.2006.01526.x","article-title":"Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: Where will MELD lead us?","volume":"6","author":"Gonwa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(89)80032-0","article-title":"Renal vascular and thrombotic effects of cyclosporine","volume":"13","author":"Remuzzi","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.13765_bib47","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1600-6143.2011.03841.x","article-title":"Thrombotic microangiopathy after living-donor liver transplantation","volume":"12","author":"Shindoh","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.blre.2014.09.001","article-title":"De novo thrombotic microangiopathy after non-renal solid organ transplantation","volume":"28","author":"Verbiest","year":"2014","journal-title":"Blood Rev"},{"key":"10.1111\/ajt.13765_bib49","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/tri.12138","article-title":"Risk factors for acute renal injury in living donor liver transplantation: Evaluation of the RIFLE criteria","volume":"26","author":"Utsumi","year":"2013","journal-title":"Transpl Int"},{"key":"10.1111\/ajt.13765_bib50","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.20490","volume":"11","author":"Yoshida","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: The \u2018ReSpECT\u2019 study","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib52","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/TP.0b013e3181db8cf0","article-title":"Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients","volume":"89","author":"Calmus","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1600-6143.2011.03486.x","article-title":"Reduced-dose tacrolimus with mycophenolate mofetil versus standard-dose tacrolimus in liver transplantation: A randomized study","volume":"11","author":"Boudjema","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib54","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/ajt.12810","article-title":"Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study","volume":"14","author":"Klintmalm","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib55","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/ajt.12543","article-title":"De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: The 2000-2003 phase II prospective randomized trial","volume":"14","author":"Asrani","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/lt.23658","article-title":"Calcineurin inhibitor-free mycophenolate mofetil\/sirolimus maintenance in liver transplantation: The randomized spare-the-nephron trial","volume":"19","author":"Teperman","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib57","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: A randomized controlled trial","volume":"12","author":"De Simone","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib58","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/ajt.12280","article-title":"Renal function at two years in liver transplant patients receiving everolimus: Results of a randomized, multicenter study","volume":"13","author":"Saliba","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib59","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0000000000000555","article-title":"Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: Follow-up results from a randomized, Multicenter Study","volume":"99","author":"Fischer","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib60","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1600-6143.2012.04049.x","article-title":"A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation\u2013PROTECT","volume":"12","author":"Fischer","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib61","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/ajt.12615","article-title":"Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation","volume":"14","author":"Sterneck","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib62","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.transproceed.2009.06.152","article-title":"Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: Clinical results of a prospective randomized study","volume":"41","author":"Beckebaum","year":"2009","journal-title":"Transpl Proc"},{"key":"10.1111\/ajt.13765_bib63","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/lt.24172","article-title":"Renal function improvement in liver transplant recipients after early everolimus conversion: a clinical practice cohort study in Spain","volume":"21","author":"Bilbao","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib64","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/lt.21920","article-title":"Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction","volume":"15","author":"Castroagudin","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib65","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/lt.21827","article-title":"Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial","volume":"15","author":"De Simone","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib66","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10620-010-1386-z","article-title":"Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunction","volume":"56","author":"Kornberg","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1111\/ajt.13765_bib67","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/lt.20903","article-title":"Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation","volume":"12","author":"Pageaux","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib68","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/lt.22292","article-title":"Conversion to everolimus in maintenance liver transplant patients: A multicenter, retrospective analysis","volume":"17","author":"Saliba","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib69","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ctr.12097","article-title":"Effects of mycophenolate mofetil introduction in liver transplant patients: Results from an observational, non-interventional, multicenter study (LOBSTER)","volume":"27","author":"Schlitt","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.13765_bib70","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1600-6143.2011.03919.x","article-title":"Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: A randomized trial","volume":"12","author":"Abdelmalek","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib71","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/j.1600-6143.2012.04157.x","article-title":"Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: A systematic review of randomized controlled trials","volume":"12","author":"Goralczyk","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib72","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/TP.0b013e31822d880d","article-title":"Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial","volume":"92","author":"Schmeding","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib73","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(00)04065-4","article-title":"Mycophenolate mofetil monotherapy in liver transplantation","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1111\/ajt.13765_bib74","first-page":"1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"2013","year":"2012","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13765_bib75","first-page":"337","article-title":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"Suppl 2","year":"2012","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13765_bib76","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1681\/ASN.2006101081","article-title":"Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease","volume":"18","author":"Kent","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13765_bib77","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1111\/ajt.13765_bib78","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2010.12.021","article-title":"Management of hypertension in liver transplant patients","volume":"152","author":"Najeed","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1111\/ajt.13765_bib79","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00007890-200112150-00013","article-title":"Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared with lisinopril","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib80","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ki.1993.61","article-title":"Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants","volume":"43","author":"Mourad","year":"1993","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13765_bib81","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000093833","article-title":"An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease","volume":"26","author":"Jones-Burton","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1111\/ajt.13765_bib82","first-page":"CD001892","article-title":"Low protein diets for chronic kidney disease in non diabetic adults","author":"Fouque","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ajt.13765_bib83","first-page":"CD002181","article-title":"Protein restriction for diabetic renal disease","author":"Robertson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ajt.13765_bib84","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ki.2013.401","article-title":"Bicarbonate therapy for prevention of chronic kidney disease progression","volume":"85","author":"Loniewski","year":"2014","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.13765_bib85","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-151-9-200911030-00008","article-title":"Systematic review: Sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy","volume":"151","author":"Zoungas","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/ajt.13765_bib86","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ahj.2006.09.014","article-title":"N-acetylcysteine in the prevention of contrast-induced nephropathy: Publication bias perpetuated by meta-analyses","volume":"153","author":"Vaitkus","year":"2007","journal-title":"Am Heart J"},{"key":"10.1111\/ajt.13765_bib87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0966-3274(94)90080-9","article-title":"Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies","volume":"2","author":"Saidman","year":"1994","journal-title":"Transpl Immunol"},{"key":"10.1111\/ajt.13765_bib88","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00007890-200104270-00025","article-title":"Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation","volume":"71","author":"Neumann","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib89","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0b013e3182184181","article-title":"Combined liver-kidney transplants: Allosensitization and recipient outcomes","volume":"91","author":"Askar","year":"2011","journal-title":"Transplantation"},{"issue":"1 Suppl 1","key":"10.1111\/ajt.13765_bib90","first-page":"88","article-title":"Combined liver-kidney transplantation: Analysis of patients with preformed lymphocytotoxic antibodies","volume":"20","author":"Fung","year":"1988","journal-title":"Transpl Proc"},{"key":"10.1111\/ajt.13765_bib91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-6143.2006.01592.x","article-title":"Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients","volume":"7","author":"Olausson","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib92","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1600-6143.2011.03467.x","article-title":"Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver\/kidney transplants","volume":"11","author":"Dar","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib93","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/00007890-199605150-00021","article-title":"The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor","volume":"61","author":"Katznelson","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib94","first-page":"331","article-title":"Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch","volume":"50","author":"Eid","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib95","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-0012.1989.tb00531.x","article-title":"Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys","volume":"3","author":"Starzl","year":"1989","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.13765_bib96","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/ajt.12147","article-title":"Class II alloantibody and mortality in simultaneous liver-kidney transplantation","volume":"13","author":"O\u2019Leary","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib97","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/ajt.12667","article-title":"The role of donor-specific HLA alloantibodies in liver transplantation","volume":"14","author":"O\u2019Leary","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib98","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2014.08.037","article-title":"Incidence and impact of rejection following simultaneous liver-kidney transplantation","volume":"62","author":"Nilles","year":"2015","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.13765_bib99","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ajt.13476","article-title":"Proposed diagnostic criteria for chronic antibody-mediated rejection in liver allografts","volume":"16","author":"O\u2019Leary","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/TP.0000000000000869","article-title":"The influence of immunosuppressive agents on the risk of de novo donor-specific HLA antibody production in solid organ transplant recipients","volume":"100","author":"O\u2019Leary","year":"2016","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13765_bib101","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1600-6143.2012.03995.x","article-title":"Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year","volume":"12","author":"Taner","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib102","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13765_bib103","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/lt.20657","article-title":"Cystatin C as a marker of renal function immediately after liver transplantation","volume":"12","author":"Biancofiore","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib104","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/j.transproceed.2007.03.107","article-title":"Alternative definition of acute kidney injury following liver transplantation: Based on serum creatinine and cystatin C levels","volume":"39","author":"Ling","year":"2007","journal-title":"Transpl Proc"},{"key":"10.1111\/ajt.13765_bib105","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1515\/CCLM.2008.052","article-title":"A new serum cystatin C-based equation for assessing glomerular filtration rate in liver transplantation","volume":"46","author":"Ling","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/ajt.13765_bib106","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/lt.20881","article-title":"Estimation of glomerular filtration rates after orthotopic liver transplantation: Evaluation of cystatin C-based equations","volume":"12","author":"Gerhardt","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.13765_bib107","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/j.1600-6143.2011.03669.x","article-title":"Clinical and plasma proteomic markers correlating with chronic kidney disease after liver transplantation","volume":"11","author":"Levitsky","year":"2011","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13765","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13765","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.13765","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.13765","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522007948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522007948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.13765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:13:56Z","timestamp":1761628436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522007948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":107,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1600613522007948"],"URL":"https:\/\/doi.org\/10.1111\/ajt.13765","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protecting the Kidney in Liver Transplant Recipients: Practicee-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.13765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}